Antigen processing by nardilysin and thimet oligopeptidase generates cytotoxic T cell epitopes

Abstract

Cytotoxic T lymphocytes (CTLs) recognize peptides presented by HLA class I molecules on the cell surface. The C terminus of these CTL epitopes is considered to be produced by the proteasome. Here we demonstrate that the cytosolic endopeptidases nardilysin and thimet oligopeptidase (TOP) complemented proteasome activity. Nardilysin and TOP were required, either together or alone, for the generation of a tumor-specific CTL epitope from PRAME, an immunodominant CTL epitope from Epstein-Barr virus protein EBNA3C, and a clinically important epitope from the melanoma protein MART-1. TOP functioned as C-terminal trimming peptidase in antigen processing, and nardilysin contributed to both the C-terminal and N-terminal generation of CTL epitopes. By broadening the antigenic peptide repertoire, nardilysin and TOP strengthen the immune defense against intracellular pathogens and cancer.

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

Figure 1: PRA(190–198) is an HLA-A3-presented CTL epitope with a proteasome-independent C terminus.
Figure 2: Nardilysin produces precursors of PRA(190–198) with C-terminal extension.
Figure 3: TOP produces the C terminus of the PRA(190–198) epitope.
Figure 4: Role of nardilysin in HLA class I antigen processing.
Figure 5: The epitope-generating trimming capacity of TOP.
Figure 6: TOP-dependent presentation by HLA-A2 of the MART-1 CTL epitope.

Accession codes

Accessions

GenBank/EMBL/DDBJ

References

  1. 1

    Rock, K.L., York, I.A. & Goldberg, A.L. Post-proteasomal antigen processing for major histocompatibility complex class I presentation. Nat. Immunol. 5, 670–677 (2004).

    CAS  Article  Google Scholar 

  2. 2

    Shastri, N., Cardinaud, S., Schwab, S.R., Serwold, T. & Kunisawa, J. All the peptides that fit: the beginning, the middle, and the end of the MHC class I antigen-processing pathway. Immunol. Rev. 207, 31–41 (2005).

    CAS  Article  Google Scholar 

  3. 3

    Yewdell, J.W. Plumbing the sources of endogenous MHC class I peptide ligands. Curr. Opin. Immunol. 19, 79–86 (2007).

    CAS  Article  Google Scholar 

  4. 4

    Reits, E. et al. A major role for TPPII in trimming proteasomal degradation products for MHC class I antigen presentation. Immunity 20, 495–506 (2004).

    CAS  Article  Google Scholar 

  5. 5

    York, I.A. et al. The cytosolic endopeptidase, thimet oligopeptidase, destroys antigenic peptides and limits the extent of MHC class I antigen presentation. Immunity 18, 429–440 (2003).

    CAS  Article  Google Scholar 

  6. 6

    Saric, T., Graef, C.I. & Goldberg, A.L. Pathway for degradation of peptides generated by proteasomes: a key role for thimet oligopeptidase and other metallopeptidases. J. Biol. Chem. 279, 46723–46732 (2004).

    CAS  Article  Google Scholar 

  7. 7

    Saveanu, L. et al. Concerted peptide trimming by human ERAP1 and ERAP2 aminopeptidase complexes in the endoplasmic reticulum. Nat. Immunol. 6, 689–697 (2005).

    CAS  Article  Google Scholar 

  8. 8

    Craiu, A., Akopian, T., Goldberg, A. & Rock, K.L. Two distinct proteolytic processes in the generation of a major histocompatibility complex class I-presented peptide. Proc. Natl. Acad. Sci. USA 94, 10850–10855 (1997).

    CAS  Article  Google Scholar 

  9. 9

    Stoltze, L. et al. Generation of the vesicular stomatitis virus nucleoprotein cytotoxic T lymphocyte epitope requires proteasome-dependent and -independent proteolytic activities. Eur. J. Immunol. 28, 4029–4036 (1998).

    CAS  Article  Google Scholar 

  10. 10

    Mo, X.Y., Cascio, P., Lemerise, K., Goldberg, A.L. & Rock, K. Distinct proteolytic processes generate the C and N termini of MHC class I-binding peptides. J. Immunol. 163, 5851–5859 (1999).

    CAS  PubMed  Google Scholar 

  11. 11

    Benham, A.M., Gromme, M. & Neefjes, J. Allelic differences in the relationship between proteasome activity and MHC class I peptide loading. J. Immunol. 161, 83–89 (1998).

    CAS  PubMed  Google Scholar 

  12. 12

    Luckey, C.J. et al. Proteasomes can either generate or destroy MHC class I epitopes: evidence for nonproteasomal epitope generation in the cytosol. J. Immunol. 161, 112–121 (1998).

    CAS  PubMed  Google Scholar 

  13. 13

    Schwarz, K. et al. The selective proteasome inhibitors lactacystin and epoxomicin can be used to either up- or down-regulate antigen presentation at nontoxic doses. J. Immunol. 164, 6147–6157 (2000).

    CAS  Article  Google Scholar 

  14. 14

    Luckey, C.J. et al. Differences in the expression of human class I MHC alleles and their associated peptides in the presence of proteasome inhibitors. J. Immunol. 167, 1212–1221 (2001).

    CAS  Article  Google Scholar 

  15. 15

    Marcilla, M., Cragnolini, J.J. & Lopez de Castro, J.A. Proteasome-independent HLA-B27 ligands arise mainly from small basic proteins. Mol. Cell. Proteomics 6, 923–938 (2007).

    CAS  Article  Google Scholar 

  16. 16

    Seifert, U. et al. An essential role for tripeptidyl peptidase in the generation of an MHC class I epitope. Nat. Immunol. 4, 375–379 (2003).

    CAS  Article  Google Scholar 

  17. 17

    Parmentier, N. et al. Production of an antigenic peptide by insulin-degrading enzyme. Nat. Immunol. 11, 449–454 (2010).

    CAS  Article  Google Scholar 

  18. 18

    van Endert, P. Role of tripeptidyl peptidase II in MHC class I antigen processing - the end of controversies? Eur. J. Immunol. 38, 609–613 (2008).

    CAS  Article  Google Scholar 

  19. 19

    Tenzer, S. et al. Modeling the MHC class I pathway by combining predictions of proteasomal cleavage, TAP transport and MHC class I binding. Cell. Mol. Life Sci. 62, 1025–1037 (2005).

    CAS  Article  Google Scholar 

  20. 20

    Kessler, J.H. et al. Efficient identification of novel HLA-A(*)0201-presented cytotoxic T lymphocyte epitopes in the widely expressed tumor antigen PRAME by proteasome-mediated digestion analysis. J. Exp. Med. 193, 73–88 (2001).

    CAS  Article  Google Scholar 

  21. 21

    Geier, E. et al. A giant protease with potential to substitute for some functions of the proteasome. Science 283, 978–981 (1999).

    CAS  Article  Google Scholar 

  22. 22

    Fumagalli, P. et al. Human NRD convertase: a highly conserved metalloendopeptidase expressed at specific sites during development and in adult tissues. Genomics 47, 238–245 (1998).

    CAS  Article  Google Scholar 

  23. 23

    Chow, K.M. et al. Studies on the subsite specificity of rat nardilysin (N-arginine dibasic convertase). J. Biol. Chem. 275, 19545–19551 (2000).

    CAS  Article  Google Scholar 

  24. 24

    Chow, K.M. et al. Nardilysin cleaves peptides at monobasic sites. Biochemistry 42, 2239–2244 (2003).

    CAS  Article  Google Scholar 

  25. 25

    Knight, C.G., Dando, P.M. & Barrett, A.J. Thimet oligopeptidase specificity: evidence of preferential cleavage near the C-terminus and product inhibition from kinetic analysis of peptide hydrolysis. Biochem. J. 308, 145–150 (1995).

    CAS  Article  Google Scholar 

  26. 26

    Oliveira, V. et al. Temperature and salts effects on the peptidase activities of the recombinant metallooligopeptidases neurolysin and thimet oligopeptidase. Eur. J. Biochem. 269, 4326–4334 (2002).

    CAS  Article  Google Scholar 

  27. 27

    Oliveira, V. et al. Substrate specificity characterization of recombinant metallo oligo-peptidases thimet oligopeptidase and neurolysin. Biochemistry 40, 4417–4425 (2001).

    CAS  Article  Google Scholar 

  28. 28

    van Swieten, P.F. et al. A cell-permeable inhibitor and activity-based probe for the caspase-like activity of the proteasome. Bioorg. Med. Chem. Lett. 17, 3402–3405 (2007).

    CAS  Article  Google Scholar 

  29. 29

    Altfeld, M. et al. HLA Alleles associated with delayed progression to AIDS contribute strongly to the initial CD8+ T cell response against HIV-1. PLoS Med. 3, e403 (2006).

    Article  Google Scholar 

  30. 30

    Brooks, J.M., Murray, R.J., Thomas, W.A., Kurilla, M.G. & Rickinson, A.B. Different HLA-B27 subtypes present the same immunodominant Epstein-Barr virus peptide. J. Exp. Med. 178, 879–887 (1993).

    CAS  Article  Google Scholar 

  31. 31

    Sigman, J.A. et al. Flexibility in substrate recognition by thimet oligopeptidase as revealed by denaturation studies. Biochem. J. 388, 255–261 (2005).

    CAS  Article  Google Scholar 

  32. 32

    Kawakami, Y. et al. Identification of the immunodominant peptides of the MART-1 human melanoma antigen recognized by the majority of HLA-A2-restricted tumor infiltrating lymphocytes. J. Exp. Med. 180, 347–352 (1994).

    CAS  Article  Google Scholar 

  33. 33

    Romero, P. et al. Cytolytic T lymphocyte recognition of the immunodominant HLA-A*0201-restricted Melan-A/MART-1 antigenic peptide in melanoma. J. Immunol. 159, 2366–2374 (1997).

    CAS  PubMed  Google Scholar 

  34. 34

    Le Gall, S., Stamegna, P. & Walker, B.D. Portable flanking sequences modulate CTL epitope processing. J. Clin. Invest. 117, 3563–3575 (2007).

    CAS  Article  Google Scholar 

  35. 35

    Schneider, J., Brichard, V., Boon, T., Meyer zum Buschenfelde, K.H. & Wolfel, T. Overlapping peptides of melanocyte differentiation antigen Melan-A/MART- 1 recognized by autologous cytolytic T lymphocytes in association with HLA-B45.1 and HLA-A2.1. Int. J. Cancer 75, 451–458 (1998).

    CAS  Article  Google Scholar 

  36. 36

    Silva, C.L., Portaro, F.C., Bonato, V.L., de Camargo, A.C. & Ferro, E.S. Thimet oligopeptidase (EC 3.4.24.15), a novel protein on the route of MHC class I antigen presentation. Biochem. Biophys. Res. Commun. 255, 591–595 (1999).

    CAS  Article  Google Scholar 

  37. 37

    Portaro, F.C. et al. Thimet oligopeptidase and the stability of MHC class I epitopes in macrophage cytosol. Biochem. Biophys. Res. Commun. 255, 596–601 (1999).

    CAS  Article  Google Scholar 

  38. 38

    Saric, T. et al. Major histocompatibility complex class I-presented antigenic peptides are degraded in cytosolic extracts primarily by thimet oligopeptidase. J. Biol. Chem. 276, 36474–36481 (2001).

    CAS  Article  Google Scholar 

  39. 39

    Kim, S.I., Pabon, A., Swanson, T.A. & Glucksman, M.J. Regulation of cell-surface major histocompatibility complex class I expression by the endopeptidase EC3.4.24.15 (thimet oligopeptidase). Biochem. J. 375, 111–120 (2003).

    CAS  Article  Google Scholar 

  40. 40

    Berti, D.A. et al. Analysis of intracellular substrates and products of thimet oligopeptidase (EC 3.4.24.15) in human embryonic kidney 293 cells. J. Biol. Chem. 284, 14105–14116 (2009).

    CAS  Article  Google Scholar 

  41. 41

    Herberts, C.A. et al. Cutting edge: HLA-B27 acquires Many N-terminal dibasic peptides: coupling cytosolic peptide stability to antigen presentation. J. Immunol. 176, 2697–2701 (2006).

    CAS  Article  Google Scholar 

  42. 42

    Csuhai, E., Chen, G. & Hersh, L.B. Regulation of N-arginine dibasic convertase activity by amines: putative role of a novel acidic domain as an amine binding site. Biochemistry 37, 3787–3794 (1998).

    CAS  Article  Google Scholar 

  43. 43

    Mulder, A. et al. Human monoclonal HLA antibodies reveal interspecies crossreactive swine MHC class I epitopes relevant for xenotransplantation. Mol. Immunol. 47, 809–815 (2010).

    CAS  Article  Google Scholar 

  44. 44

    Kessler, J.H. et al. Competition-based cellular peptide binding assays for 13 prevalent HLA class I alleles using fluorescein-labeled synthetic peptides. Hum. Immunol. 64, 245–255 (2003).

    CAS  Article  Google Scholar 

  45. 45

    Kessler, B.M. et al. Extended peptide-based inhibitors efficiently target the proteasome and reveal overlapping specificities of the catalytic beta-subunits. Chem. Biol. 8, 913–929 (2001).

    CAS  Article  Google Scholar 

  46. 46

    Balow, R.M., Tomkinson, B., Ragnarsson, U. & Zetterqvist, O. Purification, substrate specificity, and classification of tripeptidyl peptidase II. J. Biol. Chem. 261, 2409–2417 (1986).

    CAS  PubMed  Google Scholar 

  47. 47

    Tomkinson, B. & Zetterqvist, O. Immunological cross-reactivity between human tripeptidyl peptidase II and fibronectin. Biochem. J. 267, 149–154 (1990).

    CAS  Article  Google Scholar 

  48. 48

    Roelse, J., Gromme, M., Momburg, F., Hammerling, G. & Neefjes, J. Trimming of TAP-translocated peptides in the endoplasmic reticulum and in the cytosol during recycling. J. Exp. Med. 180, 1591–1597 (1994).

    CAS  Article  Google Scholar 

  49. 49

    Neisig, A. et al. Major differences in transporter associated with antigen presentation (TAP)-dependent translocation of MHC class I- presentable peptides and the effect of flanking sequences. J. Immunol. 154, 1273–1279 (1995).

    CAS  PubMed  Google Scholar 

  50. 50

    Androlewicz, M.J. & Cresswell, P. Human transporters associated with antigen processing possess a promiscuous peptide-binding site. Immunity 1, 7–14 (1994).

    CAS  Article  Google Scholar 

Download references

Acknowledgements

We thank T. Dannenberg and K. Textoris-Taube for technical assistance. Supported by the Dutch Cancer Society (UL 2005-3245) and Stichting Vanderes.

Author information

Affiliations

Authors

Contributions

J.H.K. conceived of the study, coordinated the work, designed, did and analyzed most experiments and wrote the manuscript with major input from C.J.M.M. and minor input from other authors; C.J.M.M., F.O. and P.A.v.V. provided intellectual input; S.K. did the experiments and analyses in Figure 2b and immunoblot analysis; K.M.C., L.B.H. and A. Prat contributed to the experiments about nardilysin; D.W.R., K.R., U.S. and A. Paschen contributed to the experiments about TOP; P.M.K., U.S. and B.T. contributed to the experiments about TPPII; H.S.O. and P.F.v.S. contributed to the experiments about the proteasome; J.N. and T.v.H. contributed to the experiments about TAP; N.v.M., U.S., A. Paschen, S.L.G. and J.M.B. contributed to CTL experiments; J.W.D., F.O., J.N., S.K. and W.E.B. contributed to substrate design and synthesis; S.A.B.-V. and K.L.M.C.F. contributed to the molecular biology; A.M. and I.I.N.D. made HLA class I mAbs and cell lines expressing a single HLA class I allele; and P.A.v.V. and A.d.R. did mass spectrometry.

Corresponding author

Correspondence to Jan H Kessler.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Supplementary information

Supplementary Text and Figures

Supplementary Figures 1–12 and Supplementary Tables 1–2 (PDF 3479 kb)

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Kessler, J., Khan, S., Seifert, U. et al. Antigen processing by nardilysin and thimet oligopeptidase generates cytotoxic T cell epitopes. Nat Immunol 12, 45–53 (2011). https://doi.org/10.1038/ni.1974

Download citation

Further reading